Original
Impacto presupuestario del tratamiento antirretroviral. Reflexión desde las guías de GESIDA
Budget impact analysis of antiretroviral therapy. A reflection based on the GESIDA guidelines
Grupo de trabajo de la Cohorte VACH ◊
Asociación Médica AM-VACH, Huelva, España
Leído
2364
Vecesse ha leído el artículo
673
Total PDF
1691
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 127 | 72 | 199 |
| 2025 5 | 146 | 27 | 173 |
| 2025 4 | 169 | 29 | 198 |
| 2025 3 | 98 | 26 | 124 |
| 2025 2 | 102 | 24 | 126 |
| 2025 1 | 54 | 30 | 84 |
| 2024 12 | 59 | 29 | 88 |
| 2024 11 | 84 | 51 | 135 |
| 2024 10 | 71 | 51 | 122 |
| 2024 9 | 58 | 30 | 88 |
| 2024 8 | 63 | 28 | 91 |
| 2024 7 | 45 | 24 | 69 |
| 2024 6 | 69 | 22 | 91 |
| 2024 5 | 38 | 23 | 61 |
| 2024 4 | 46 | 12 | 58 |
| 2024 3 | 58 | 20 | 78 |
| 2024 2 | 41 | 32 | 73 |
| 2024 1 | 44 | 14 | 58 |
| 2023 12 | 37 | 16 | 53 |
| 2023 11 | 50 | 19 | 69 |
| 2023 10 | 34 | 17 | 51 |
| 2023 9 | 40 | 11 | 51 |
| 2023 8 | 31 | 15 | 46 |
| 2023 7 | 57 | 26 | 83 |
| 2023 6 | 46 | 12 | 58 |
| 2023 5 | 24 | 13 | 37 |
Mostrar todo
